KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Encompass Health (EHC) Current Leases (2017 - 2026)

Encompass Health (EHC) has disclosed Current Leases for 10 consecutive years, with $26.9 million as the latest value for Q1 2026.

  • For Q1 2026, Current Leases rose 0.75% year-over-year to $26.9 million; the TTM value through Mar 2026 reached $26.9 million, up 0.75%, while the annual FY2025 figure was $26.5 million, 0.76% up from the prior year.
  • Current Leases hit $26.9 million in Q1 2026 for Encompass Health, up from $26.5 million in the prior quarter.
  • Across five years, Current Leases topped out at $38.4 million in Q1 2022 and bottomed at $22.7 million in Q3 2022.
  • Average Current Leases over 5 years is $27.1 million, with a median of $26.3 million recorded in 2023.
  • Year-over-year, Current Leases tumbled 44.23% in 2022 and then grew 9.69% in 2023.
  • Encompass Health's Current Leases stood at $25.6 million in 2022, then fell by 5.86% to $24.1 million in 2023, then grew by 9.13% to $26.3 million in 2024, then grew by 0.76% to $26.5 million in 2025, then grew by 1.51% to $26.9 million in 2026.
  • According to Business Quant data, Current Leases over the past three periods came in at $26.9 million, $26.5 million, and $25.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.